Neopterin and RANTES content in serum of patients with infiltrative and disseminated tuberculosis

Cover Page

Cite item

Full Text

Open Access Open Access
Restricted Access Access granted
Restricted Access Subscription or Fee Access

Abstract

The problem of tuberculosis (TB) remains a priority in public health worldwide and in the Russian Federation. Approaches to diagnosis and treatment are being improved. There are scientific background for using neopterin and RANTES as integral indicators of TB current severity, but more research is need in this area. Objective. To study RANTES and neopterin content in blood serum of patients with destructive infiltrative and disseminated TB to distinguish a group of patients with acute progression. Material and methods. The content of neopterin and RANTES in 72 patients with destructive infiltrative and disseminated TB and 30 healthy donors was studied by enzyme immunoassay. The TB patients were divided into 2 groups: 36 patients with acute progression and 36 patients without signs of acute progression. Results. The serum levels of neopterin and RANTES were significantly increased in patients with infiltrative and disseminated TB. Herewith the level of increase correlates with the severity of the progression. The increase of neopterin was found to correlate with the infiltration area and destruction size as well as with the increase of C-reactive protein and erythrocyte sedimentation rate (ESR). RANTES increase correlated with infiltration area, destruction size and ESR. Conclusion. The results of the study allow to consider increase of neopterin and RANTES contents as additional objective criteria of acute progression of infiltrative and disseminated TB.

Full Text

Restricted Access

About the authors

O. G Chelnokova

Yaroslavl State Medical University of the Ministry of Healthcare of Russia

Email: chelnokova@bk.ru
Associate Professor

A. A Baranov

Yaroslavl State Medical University of the Ministry of Healthcare of Russia

Email: chelnokova@bk.ru

Professor

A. Takhkhan

Yaroslavl Regional Clinical Tuberculosis Hospital

Author for correspondence.
Email: chelnokova@bk.ru

References

  1. Васильева И.А., Белиловский Е.М., Борисов С.Е. и др. Заболеваемость, смертность и распространенность как показатели бремени туберкулеза в регионах ВОЗ, странах мира и в Российской Федерации. Туберкулез и болезни легких. 2017; 95 (6): 9-21 doi: 10.21292/2075-1230-2017-95-6-9-21
  2. Эргешов А.Э. Туберкулез в Российской Федерации: ситуация, проблемы и перспективы. Вестник РАМН. 2018; 73 (5): 330-7 doi: 10.15690/vramn1023
  3. Эпидемическая ситуация по туберкулезу в Российской Федерации в 2017 г. Федеральный центр мониторинга противодействия распространению туберкулеза в РФ [Epidemicheskaya situatsiya po tuberkulezu v Rossiiskoi Federatsii v 2017 g. Federal’nyi tsentr monitoringa protivodeistviya rasprostraneniyu tuberkuleza v RF (in Russ.)]. URL: https://mednet.ru/images/materials/CMT/tuberkulez-2019.pdf
  4. Ерохин В.В., Земскова З.С., Шилова М.В. Патологическая анатомия туберкулеза. М., 2000; 149 с.
  5. Кудлай Д.А. Биомаркеры и иммунологические тесты. Экспериментальноклинические параллели латентной туберкулезной инфекции. Туберкулез и болезни легких. 2020; 98 (8): 63-74 doi: 10.21292/2075-1230-2020-98-8-63-74
  6. Хоменко А.Г., Мишин В.Ю., Чуканов В.И. и др. Диагностика, клиника и тактика лечения остропрогрессирующих форм туберкулеза легких в современных эпидемиологических условиях. Проблемы туберкулеза. 1999; 1: 22-7
  7. Чурина Е.Г., Ситникова А.В., Уразова О.И. и др. Макрофаги при бактериальных болезнях легких: фенотип и функции (обзор). Бюллетень сибирской медицины. 2019; 18 (1): 142-54 doi: 10.20538/1682-03632019-1-142-154
  8. Эсмедляева Д.С., Алексеева Н.П., Павлова М.В. и др. Неоптерин сыворотки крови как интегральный показатель активности процесса у больных инфильтративным туберкулезом легких. Медицинский альянс. 2016; 2: 20-5
  9. Eisenhut M. Neopterin in Diagnosis and Monitoring of Infectious Diseases. J. Biomark. 2013; 2013: 196432. doi: 10.1155/2013/196432
  10. Zhao Y., Yang X., Zhang X. et al. IP-10 and RANTES as biomarkers for pulmonary tuberculosis diagnosis and monitoring. Tuberculosis (Edinb). 2018; 111: 45-53. doi: 10.1016/j.tube.2018.05.004
  11. Schall T.J. Biology of the RANTES/SIS cytokine family. Cytokine. 1991; 3 (3): 165-83. doi: 10.1016/1043-4666(91)90013-4
  12. Gunja Mishra, Satish S. Poojary, Sanjay Jain et al. Genotype-phenotype relationship of CCL5 in pulmonary tuberculosis infection in Sahariya tribe: A pilot study. Indian J. Med Res. 2017; 146 (6): 768-73. doi: 10.4103/ijmr. IJMR_1582_15
  13. Ерохин В.В., Мишин В.Ю., Чуканов В.И. и др. Казеозная пневмония. М.: Медицина, 2008; 191 с.
  14. Челнокова О.Г. Особенности диагностики и лечения остропрогрессирующих деструктивных форм туберкулеза легких. Дисс. д-ра мед. наук. М., 2007; 377 с.

Supplementary files

Supplementary Files
Action
1. JATS XML

Copyright (c) 2022 Russkiy Vrach Publishing House

This website uses cookies

You consent to our cookies if you continue to use our website.

About Cookies